Navigation Links
Aratana Therapeutics Reports Third Quarter 2013 Financial Results
Date:11/13/2013

ve medications for pets, or pet therapeutics. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to pets in a capital and time efficient manner.  Aratana's strategy is to in-license proprietary compounds from human biopharmaceutical companies and to develop these product candidates into therapeutics specifically for use in pets. Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets. For more information, please visit www.aratana.com.

Forward-Looking Statements Disclaimer 
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding the expansion of our commercial infrastructure; expectations regarding development programs, trials, studies, and approval; expectations regarding cash and cash equivalent balances; statement regarding the sufficiency of cash and cash equivalents; expectations regarding in-license initiatives; and expectations regarding the Company's plans and opportunities. 

These forward-looking statements are based on management's current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: our limited operating history and expectations of losses for the foreseeab
'/>"/>

SOURCE Aratana Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Aratana to Participate in Leerink Swanns November Management Access Days
2. Aratana to Present at Bank of America Merrill Lynch Animal Health Summit
3. Aratana Therapeutics Appoints Erick Lucera Vice President of Corporate Development
4. Aratana Closes $12 Million Series C Financing to Fund Pipeline Expansion
5. Aratana Therapeutics to Present at Two Upcoming Healthcare Conferences
6. Aratana Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
7. Aratana Therapeutics Reports Second Quarter 2013 Financial Results
8. Aratana Therapeutics to Host Pet Therapeutics Primer and Product Update Event
9. Aratana Therapeutics Drives Awareness of Pet Therapeutic Opportunity During "CVC Week" in Kansas City
10. Aratana Therapeutics to Present at BioCenturys NewsMakers in the Biotech Industry Conference
11. Aratana Therapeutics names Wendy Yarno to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... BURLINGTON, Mass. , Sept. 18, 2014  Decision ... launched anti-vascular endothelial growth factor (VEGF) agent for wet ... and Medicare Advantage plans as Genentech,s Lucentis, which is ... although surveyed managed care organization (MCO) directors do not ... Eylea is slightly more likely than Lucentis to be ...
(Date:9/18/2014)... Pa. , Sept. 18, 2014 /PRNewswire/ ... solutions, was recognized as the Disruptive Innovator ... its ePharmaONE cloud-based eClinical platform. This solution ... electronic trial master file (eTMF), a remote ... and ePharmaSolutions, ReferralPlus+ patient screening and matching ...
(Date:9/18/2014)... Sept. 18, 2014  A $3 million grant from ... University of Michigan to establish a national center of ... Center for Aging Research at U-M will focus on ... slow the effects of aging and postpone diseases in ... that can help develop medications that may help people ...
Breaking Medicine Technology:Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 2Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 3ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform 2ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform 3$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 3
... bolstering current systems for assessing and monitoring drug safety, researchers ... combines multiple forms of widely available data to predict adverse ... of drug safety issues as they accumulate over time in ... issues years in advance. This study, led by ...
... Food and Drug Administration is warning consumers again not to ... and sold by various companies, due to serious potential health ... Massager is a personal massage device sold in retail ... provide users with a deep tissue massage to the neck, ...
Cached Medicine Technology:Taking a Predictive Approach to Identifying Adverse Drug Reactions 2Taking a Predictive Approach to Identifying Adverse Drug Reactions 3FDA: Do Not Use ShoulderFlex Massagers 2FDA: Do Not Use ShoulderFlex Massagers 3
(Date:9/18/2014)... 2014 (HealthDay News) -- Older people become more physically ... the balance of stress hormones during bereavement changes with ... who are grieving are more likely to have weakened ... "During the difficult weeks and months after loss, we ... most abundant type of white blood cell and as ...
(Date:9/18/2014)... San Luis Obispo, CA (PRWEB) September 18, 2014 ... Bunion Bootie introduced their newest, patent pending bunion splint ... , As one loyalist, Rosa, wrote: "I was absolutely delighted. ... comfortable... I honestly forget I am wearing them. THANK YOU ... the recently introduced design by saying, "The hole used to ...
(Date:9/18/2014)... Mozes HealthDay Reporter , THURSDAY, ... emergency room waiting times, patients seeking care at larger urban ... clock than those seen at smaller or more rural facilities, ... ability to provide timely emergency care varies dramatically across hospitals ... the new research, Dr. Renee Hsia, an associate professor at ...
(Date:9/18/2014)... Chest Physicians (CHEST) together with the Chinese Thoracic ... of CTS that CHEST World Congress 2016 will ... critical care, and sleep medicine from around the ... slated for spring 2016. , CHEST World ... hands-on simulation training, keynote addresses, presentations by leading ...
(Date:9/18/2014)... Seattle, WA (PRWEB) September 18, 2014 ... management organizations, has published a white paper, “Advancing ... Optimization of Health Information Technology.” , Authors Jeff ... PCMH CCE provide guidance to organizations engaged in the ... showing how health IT can bolster PCMH objectives, such ...
Breaking Medicine News(10 mins):Health News:Grief Can Weigh on Immune System in Older Folks, Study Says 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3Health News:ER Waiting Times Vary Significantly, Studies Find 2Health News:ER Waiting Times Vary Significantly, Studies Find 3Health News:CHEST announces China as site of CHEST World Congress 2016 2Health News:Advancing Primary Care Through PCMH and HIT: New White Paper Connects the Dots 2
... recipient,s tissue, study finds, , SUNDAY, Nov. 22 (HealthDay ... -- a missing gene -- boosts the risk that ... complication called graft-versus-host disease. , The immune system-related ... variation and the donor does not. , When ...
... ... can be both fun and joyous. It can also be stressful and tiring ... foods -- factors that can, over time, increase your risk of cancer. That,s ... 10 Food Tips that can help ensure a happier, more healthful holiday season, ...
... WASHINGTON, Nov. 21 Tonight, in a partisan vote, the ... the government takeover of health care. Among the several objectionable ... and individual mandates, is the government funding for elective abortion, ... bill provides subsidies for private plans that cover elective abortion. ...
... Nov. 21 Milvia Lopez, by her attorney MICHAEL STEWART ... Court, New York County, bearing Index # 112888/2009. The complaint ... ("TEE") at ST. VINCENT,S HOSPITAL , doctors used an ... The complaint alleges that several hours after being discharged from ...
... , LONDON, November 21, 2009 Test Test Test ... Test Test,Test Test Test Test Test Test Test Test Test Test Test Test ... Test , More test More test More test More ... test More test More test More test More,test More test , , ...
... ... available on the iPhone and iPod Touch. , ... Mountain View, CA (PRWEB) November 21, 2009 -- HAPPYneuron,s most popular and ... designed to help banish that ,tip of the tongue, syndrome forever. , , ,The SplitWords ...
Cached Medicine News:Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3
... 4, 8, or 12 channel pipettors. Angled sides ... of the solution. Corners have pouring lips to ... polystyrene containing no regrinds. Sterile 5/bag packaging for ... mm W x 152 mm L x 35 ...
Volume: 10 ml; Volume Graduation: 1/10 ml...
... Gilsons Pipette Aid, which is for use ... rapidly, and comfortably with precision. It works with ... the volume range from 1 mL to 100 ... valve and replaceable membrane filters, which protect the ...
Inquire...
Medicine Products: